Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy PPD stock in Canada | $46.97
Own PPD shares in just a few minutes.
PPD Inc is a drug manufacturers-specialty & generic business based in the US. PPD shares (PPD) are listed on the NASDAQ and all prices are listed in US Dollars. PPD employs 28,000 staff and has a trailing 12-month revenue of around USD$5.6 billion.
How to buy shares in PPD
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – PPD – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Is it a good time to buy PPD stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
What's in this guide?
How has Coronavirus impacted PPD's stock price?
Since the stock market crash in March caused by coronavirus, PPD's stock price has had significant positive movement.
Its last market close was $46.97, which is 34.26% up on its pre-crash value of $30.88 and 342.70% up on the lowest point reached during the March crash when the stocks fell as low as $10.61.
If you had bought $1,000 worth of PPD stocks at the start of February 2020, those stocks would have been worth $inf at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $inf.
PPD stock priceUse our graph to track the performance of PPD stocks over time.
PPD shares at a glance
|Latest market close||$46.97|
|52-week range||$31.54 - $47.09|
|50-day moving average||$46.77|
|200-day moving average||$45.77|
|Wall St. target price||$47.22|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.72|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
PPD price performance over time
|1 week (2021-10-15)||0.04%|
|1 month (2021-09-22)||0.36%|
|3 months (2021-07-22)||2.11%|
|6 months (2021-04-22)||1.64%|
|1 year (2020-10-21)||29.93%|
|2 years (2019-10-18)||N/A|
|3 years (2018-10-18)||N/A|
|5 years (2016-10-18)||N/A|
Is PPD under- or over-valued?
Valuing PPD stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of PPD's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
PPD's P/E ratio
PPD's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 66x. In other words, PPD shares trade at around 66x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
PPD's PEG ratio
PPD's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.5286. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into PPD's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
PPD's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $919.9 million.
The EBITDA is a measure of a PPD's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$5.6 billion|
|Operating margin TTM||11.21%|
|Gross profit TTM||$3 billion|
|Return on assets TTM||6.15%|
|Return on equity TTM||0%|
|Market capitalisation||$16.5 billion|
TTM: trailing 12 months
Shorting PPD shares
There are currently 16.2 million PPD shares held short by investors – that's known as PPD's "short interest". This figure is 1.2% up from 16.0 million last month.
There are a few different ways that this level of interest in shorting PPD shares can be evaluated.
PPD's "short interest ratio" (SIR)
PPD's "short interest ratio" (SIR) is the quantity of PPD shares currently shorted divided by the average quantity of PPD shares traded daily (recently around 1.3 million). PPD's SIR currently stands at 12.37. In other words for every 100,000 PPD shares traded daily on the market, roughly 12370 shares are currently held short.
However PPD's short interest can also be evaluated against the total number of PPD shares, or, against the total number of tradable PPD shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case PPD's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 PPD shares in existence, roughly 50 shares are currently held short) or 0.1387% of the tradable shares (for every 100,000 tradable PPD shares, roughly 139 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against PPD.
PPD share dividends
We're not expecting PPD to pay a dividend over the next 12 months.
PPD, Inc. , together with its subsidiaries, provides drug development services to the biopharmaceutical industry worldwide. The company operates through two segments, Clinical Development Services and Laboratory Services. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri-and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. It serves pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants. The company has a collaboration with Science 37 to design, build, test, implement, and execute digital trials using Science 37's DCT SaaS-based technology platform.
Stocks similar to PPD
Frequently asked questions
PPD in the news
PPD, Inc. (PPD) Earnings Expected to Grow: Should You Buy?
PPD Named Clinical Research Company of the Year for Second Consecutive Year
PPD : Named Clinical Research Company of the Year for Second Consecutive Year
More on investing
Stock trading doesn’t have to be expensive. Using Finder’s proprietary algorithm, we’ve identified the best cheap Canadian and US stocks to buy now.Read more…
Steps to owning and managing Cue Health stocks, with 24-hour and historical pricing before you buy.Read more…
Steps to owning and managing ARBK stock, with 24-hour and historical pricing before you buy.Read more…
More guides on Finder
How to buy AirSculpt Technologies (AIRS) stock in Canada when it goes public
Everything we know about the AirSculpt Technologies IPO, plus information on how to buy in.
How to buy Candela Medical (CDLA) stock in Canada when it goes public
Everything we know about the Candela Medical IPO, plus information on how to buy in.
How to buy Ensemble Health Partners (ENSB) stock in Canada when it goes public
Everything we know about the Ensemble Health Partners IPO, plus information on how to buy in.
How to buy Fluence Energy (FLNC) stock in Canada when it goes public
Everything we know about the Fluence Energy IPO, plus information on how to buy in.
How to buy GlobalFoundries (GFS) stock in Canada when it goes public
Everything we know about the GlobalFoundries IPO, plus information on how to buy in.
How to buy LianBio (LIAN) stock in Canada when it goes public
Everything we know about the LianBio IPO, plus information on how to buy in.
How to buy Rent the Runway (RENT) stock in Canada when it goes public
Everything we know about the Rent the Runway IPO, plus information on how to buy in.
How to buy Solo Brands (DTC) stock in Canada when it goes public
Everything we know about the Solo Brands IPO, plus information on how to buy in.
How to buy Udemy (UDMY) stock in Canada when it goes public
Everything we know about the Udemy IPO, plus information on how to buy in.
How to buy Arteris (AIP) stock in Canada when it goes public
Everything we know about the Arteris IPO, plus information on how to buy in.
Ask an Expert
You must be logged in to post a comment.